Clinical study on the influence of intestinal microecology on antibody response after COVID-19 vaccination

Influence of gut microbiota on the immune response to COVID-19 vaccine

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044539

Enrollment

Unknown

Registered

2021-03-23

Start date

2021-04-01

Completion date

Unknown

Last updated

2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Case series:Receive the COVID-19 vaccination

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years male or female; 2. All the included populations voluntarily receive the COVID-19 vaccination and voluntarily join the study; 3. Healthy volunteers who meet the requirements for vaccination.

Exclusion criteria

Exclusion criteria: 1. Volunteers who have been screened and found to have contraindications for vaccination; 2. The vaccinators who refuse to join this study; 3. Persons who withdraw from the study without any reason in the middle of the study.

Design outcomes

Primary

Measure	Time frame
Gut microbiota;Neutralizing antibody level;SCFAs;	—

Countries

China

Contacts

Public ContactYang Shiming

Department of Gastroenterology, Second Affiliated Hospital of Army Medical University

13228686589@163.com+86 13228686589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026